Text Size

Assessment of Accelerometric Measurement Devices for Gait Analysis (ACCELERIX)

This study is currently recruiting participants.
Verified January 2012 by Institut de Myologie, France
Sponsor:
Information provided by (Responsible Party):
Institut de Myologie, France
ClinicalTrials.gov Identifier:
NCT01522690
First received: January 4, 2012
Last updated: May 2, 2013
Last verified: January 2012
History of Changes
  Purpose

The objective of this study is to obtain normative accelerometry data during the six minute walk test and a 30 second walk test on healthy subjects in order to determine the accelerometric variables that are the most relevant to describe gait disorders in patient populations. Secondary objectives of this study are to investigate the impact of walking speed and muscle strength on the accelerometric parameters, to assess the reproducibility of the method and to compare accelerometric data obtained with two different devices.


Condition Intervention
Healthy
 Other: Different walk tests with an accelerometer device

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Assessment of Accelerometric Measurement Devices for Gait Analysis

Resource links provided by NLM:

MedlinePlus related topics: Methamphetamine
U.S. FDA Resources

Further study details as provided by Institut de Myologie, France:

Primary Outcome Measures:
  • Accelerometric variables measured for each walk test [ Time Frame: At baseline ] [ Designated as safety issue: No ]
  • Accelerometric variables measured for each walk test [ Time Frame: 1 hour after baseline ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Gait speed measured for each walk test [ Time Frame: At baseline ] [ Designated as safety issue: No ]
  • Knee flexion and extension strength [ Time Frame: At baseline ] [ Designated as safety issue: No ]
  • Gait speed measured for each walk test [ Time Frame: 1 hour after baseline ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: December 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Different walk tests with an accelerometer device
    Subjects will performed three walk tests of 50 meter at different speeds, a six minute walk test, a walking test of 30 seconds then a test to measure the maximum force of extension and knee flexion on each leg. The walk tests will be performed with the accelerometer device (Locometrix) worn in a belt
  Eligibility

Ages Eligible for Study:   5 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy ambulant subject
  • subject affiliated to a social security system
  • subject who signed an informed consent

Exclusion Criteria:

  • surgery or recent trauma to the lower limbs (under 6 months)
  • high performance sport
  • chronic treatment alters the strength in the month before inclusion
  • pregnant or nursing woman
  • person under guardianship or curatorship
  • orthopedic, neuromuscular or neurological disease having an impact on the quality of walking
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01522690

Contacts
Contact: Jean-Yves HOGREL, PhD +33 1 42 16 58 80 jy.hogrel@institut-myologie.org
Contact: Amélie MORAUX a.moraux@institut-myologie.org

Locations
France
Institut de Myologie - GH Pitié Salpêtrière Recruiting
Paris, France
Contact: Jean-Yves HOGREL, PhD     +331 42 16 58 80     jy.hogrel@institut-myologie.org    
Contact: Amelie MORAUX     +331 42 16 58 80     a.moraux@institut-myologie.org    
Sub-Investigator: Laurent SERVAIS, PhD            
Sponsors and Collaborators
Institut de Myologie, France
  More Information

No publications provided

Responsible Party: Institut de Myologie, France
ClinicalTrials.gov Identifier: NCT01522690     History of Changes
Other Study ID Numbers: ACCELERIX
Study First Received: January 4, 2012
Last Updated: May 2, 2013
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by Institut de Myologie, France:
Accelerometer
gait analysis
Healthy subjects

ClinicalTrials.gov processed this record on May 21, 2013